Hudson Bay Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$611K	Hold	835,000	–	–	﹤0.01%	709
2025 Q1	$674K	Hold	835,000	–	–	﹤0.01%	632
2024 Q4	$1.15M	Buy	835,000 +50,000	+6%	+$69K	﹤0.01%	547
2024 Q3	$816K	Hold	785,000	–	–	﹤0.01%	504
2024 Q2	$1.36M	Buy	785,000 +85,000	+12%	+$147K	0.01%	467
2024 Q1	$1.67M	Buy	700,000 +115,000	+20%	+$275K	0.01%	408
2023 Q4	$1.95M	Buy	585,000 +175,000	+43%	+$583K	0.01%	395
2023 Q3	$1.53M	Sell	410,000 -27,500	-6%	-$103K	0.01%	442
2023 Q2	$1.87M	Buy	437,500 +287,500	+192%	+$1.23M	0.01%	454
2023 Q1	$1.03M	Hold	150,000	–	–	0.01%	545
2022 Q4	$1.19M	Buy	+150,000	New	+$1.19M	0.01%	632
2022 Q3	–	Sell	-155,000	Closed	-$1.12M	–	1190
2022 Q2	$1.12M	Buy	+155,000	New	+$1.12M	0.01%	859
2021 Q4	–	Sell	-30,000	Closed	-$482K	–	1077
2021 Q3	$482K	Sell	30,000 -55,000	-65%	-$884K	0.01%	795
2021 Q2	$1.18M	Sell	85,000 -7,500	-8%	-$104K	0.01%	687
2021 Q1	$1.35M	Buy	+92,500	New	+$1.35M	0.02%	628
2020 Q4	–	Sell	-45,000	Closed	-$825K	–	594
2020 Q3	$825K	Sell	45,000 -25,000	-36%	-$458K	0.01%	425
2020 Q2	$1.25M	Buy	70,000 +25,000	+56%	+$446K	0.02%	350
2020 Q1	$730K	Buy	45,000 +4,660	+12%	+$75.6K	0.02%	346
2019 Q4	$726K	Buy	+40,340	New	+$726K	0.02%	312
2019 Q1	–	Sell	-100,000	Closed	-$905K	–	450
2018 Q4	$905K	Buy	+100,000	New	+$905K	0.01%	363
2018 Q2	–	Sell	-23,035	Closed	-$255K	–	482
2018 Q1	$255K	Buy	+23,035	New	+$255K	0.01%	413
2015 Q4	–	Sell	-145,261	Closed	-$2.91M	–	158
2015 Q3	$2.91M	Buy	+145,261	New	+$2.91M	0.13%	76